Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-05-16

Clinical Trial Update: Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)

View source ↗

Summary

Observational study evaluating outcomes of biological treatments in rheumatoid arthritis, completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biological treatments (unspecified)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2012-05-16